QAS.AI Launches Clinical-Ready Demo, Deploys at Gates Vascular Institute

QAS.AI Launches Clinical-Ready Demo, Deploys at Gates Vascular Institute

Oct 15, 2023

We’re thrilled to announce the launch of our interactive software demo, developed in collaboration with Morehead Design, showcasing QAS.AI’s real-time AI guidance for neuroendovascular procedures.

This milestone marks the transition from prototype to clinical deployment—with our system now live and actively undergoing testing at Gates Vascular Institute, a nationally recognized center for cerebrovascular innovation.

The demo highlights QAS.AI’s ability to:

  • Automatically detect aneurysms and injection inlets

  • Analyze contrast dynamics from angiographic sequences

  • Provide probability-based predictions for aneurysm occlusion at 6 months

  • Deliver results in under 1 second, directly in the angio suite


This clinical integration represents a key step toward translating our NSF- and UB CAT-supported research into a standard-of-care decision support tool.

We’re thrilled to announce the launch of our interactive software demo, developed in collaboration with Morehead Design, showcasing QAS.AI’s real-time AI guidance for neuroendovascular procedures.

This milestone marks the transition from prototype to clinical deployment—with our system now live and actively undergoing testing at Gates Vascular Institute, a nationally recognized center for cerebrovascular innovation.

The demo highlights QAS.AI’s ability to:

  • Automatically detect aneurysms and injection inlets

  • Analyze contrast dynamics from angiographic sequences

  • Provide probability-based predictions for aneurysm occlusion at 6 months

  • Deliver results in under 1 second, directly in the angio suite


This clinical integration represents a key step toward translating our NSF- and UB CAT-supported research into a standard-of-care decision support tool.